EDP Sciences logo
Open Access
Numéro
Cah. Myol.
Numéro 25, juillet 2022
Page(s) 6 - 9
Section Mise au point / Focus
DOI https://doi.org/10.1051/myolog/202225003
Publié en ligne 11 août 2022
  1. Layzer RB, Shearn MA, Satya-Murti S. Eosinophilic polymyositis. Ann Neurol 1977 ; 1 : 65–71. [CrossRef] [PubMed] [Google Scholar]
  2. Kumamoto T, Ueyama H, Fujimoto S, et al. Clinicopathologic characteristics of polymyositis patients with numerous tissue eosinophils. Acta Neurol Scand 1996 ; 94 : 110–4. [CrossRef] [PubMed] [Google Scholar]
  3. Selva-O’Callaghan A, Trallero-Araguás E, Grau JM. Eosinophilic myositis: an updated review. Autoimmun Rev 2014 ; 13 : 375–8. [CrossRef] [PubMed] [Google Scholar]
  4. Hall FC, Krausz T, Walport MJ. Idiopathic eosinophilic myositis. QJM Mon J Assoc Physicians 1995 ; 88 (8) : 581–6. [Google Scholar]
  5. Gallay L, Hot A, Petiot P, et al. Focal myositis: New insights on diagnosis and pathology. Neurology 2018 ; 90 : e1013–20. [CrossRef] [PubMed] [Google Scholar]
  6. Muqit MMK, Taylor RH. Cyclical orbital eosinophilic myositis. Br J Ophthalmol 2007 ; 91 : 1569–70. [CrossRef] [PubMed] [Google Scholar]
  7. Galindo-Ferreiro A, Torres Nieto MA, Barbado Ajo J, et al. Focal eosinophilic myositis affecting the orbicularis muscle: Clinical and image aspects. Ophthal Plast Reconstr Surg 2020 ; 36 : e51–3. [CrossRef] [PubMed] [Google Scholar]
  8. Roh YH, Koh YD, Noh JH, et al. Focal Eosinophilic myositis of the hand presenting as a refractory pyogenic infection. J Hand Surg 2017 ; 42 (842) : e1–842.e3. [CrossRef] [Google Scholar]
  9. Sharma P, Sharma MC. Resolving Eosinophilic Myositis: MR Features. J Comput Assist Tomogr 2001 ; 25 : 151–3. [CrossRef] [PubMed] [Google Scholar]
  10. Hamada S, Ueki S, Miyabe Y, et al. Focal eosinophilic myositis with Charcot-Leyden crystal formation. Allergol Int Off J Jpn Soc Allergol 2020 ; 69 : 633–5. [CrossRef] [Google Scholar]
  11. Yamashita S, Kawasumi H, Kimura M, et al. Spontaneous resolution of focal eosinophilic myositis of the adductor pollicis complicated by lung lesions. Mod Rheumatol Case Rep 2020 : 106–9. [CrossRef] [PubMed] [Google Scholar]
  12. Nakashima M, Kawabe Y, Aoyagi T, et al. A case of eosinophilic myositis associated with orbital myositis. Mod Rheumatol 2002 ; 12 : 80–3. [CrossRef] [PubMed] [Google Scholar]
  13. Kaufman LD, Kephart GM, Seidman RJ, et al. The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum 1993 ; 36 : 1014–24. [CrossRef] [PubMed] [Google Scholar]
  14. Serratrice G, Pellissier JF, Roux H, et al. Fasciitis, perimyositis, myositis, polymyositis, and eosinophilia. Muscle Nerve 1990 ; 13 : 385–95. [CrossRef] [PubMed] [Google Scholar]
  15. Kita H, Eosinophils : multifaceted biological properties and roles in health and disease. Immunol Rev 2011 ; 242 : 161–77. [CrossRef] [PubMed] [Google Scholar]
  16. Cantarini L, Volpi N, Carbotti P, et al. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms. J Clin Pathol 2009 ; 62 : 442–7. [CrossRef] [PubMed] [Google Scholar]
  17. Sugihara R, Kumamoto T, Ito T, et al. Human muscle protein degradation in vitro by eosinophil cationic protein (ECP). Muscle Nerve 2001 ; 24 : 1627–34. [CrossRef] [PubMed] [Google Scholar]
  18. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975 ; 88 : 70–86. [PubMed] [Google Scholar]
  19. Lebeaux D, Sène D. Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 2012 ; 26 : 449–58. [CrossRef] [PubMed] [Google Scholar]
  20. Toquet C, Hamidou MA, Renaudin K, et al. In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 2003 ; 30 : 1811–5. [PubMed] [Google Scholar]
  21. El-Beshbishi SN, Ahmed NN, Mostafa SH, et al. Parasitic infections and myositis. Parasitol Res 2012 ; 110 : 1–18. [CrossRef] [PubMed] [Google Scholar]
  22. Krahn M, Goicoechea M, Hanisch F, et al. Eosinophilic infiltration related to CAPN3 mutations: a pathophysiological component of primary calpainopathy? Clin Genet 2011 ; 80 : 398–402. [CrossRef] [PubMed] [Google Scholar]
  23. Krahn M, Hanisch F, Goicoechea M, et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis: A predystrophic stage of LGMD2A? Neuromuscul Disord 2007 ; 17 : 791–2. [CrossRef] [Google Scholar]
  24. Baumeister SK, Todorovic S, Milić-Rasić V, et al. Eosinophilic myositis as presenting symptom in gamma-sarcoglycanopathy. Neuromuscul Disord 2009 ; 19 : 167–71. [CrossRef] [PubMed] [Google Scholar]
  25. Brown RH, Amato A. Calpainopathy and eosinophilic myositis. Ann Neurol 2006 ; 59 : 875–7. [CrossRef] [PubMed] [Google Scholar]
  26. Schröder T, Fuchss J, Schneider I, et al. Eosinophils in hereditary and inflammatory myopathies. Acta Myol 2013 ; 32 : 148–53. [PubMed] [Google Scholar]
  27. Parent ME, Larue S, Ellezam B. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis. BMC Musculoskelet Disord 2014 ; 15 : 388. [CrossRef] [PubMed] [Google Scholar]
  28. Uehara M, Hashimoto T, Sasahara E, et al. Churg-Strauss syndrome presenting as myositis following unaccustomed exercise. J Clin Neurosci 2009 ; 16 : 1232–3. [CrossRef] [PubMed] [Google Scholar]
  29. Tamaki H, Chatterjee S, Langford CA. Eosinophilia in Rheumatologic/Vascular Disorders. Immunol Allergy Clin North Am 2015 ; 3 : 453–76. [CrossRef] [PubMed] [Google Scholar]
  30. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009 ; 124 : 1319–25. [CrossRef] [PubMed] [Google Scholar]
  31. Waheed S, Zubair H, Waheed F. Treatment of eosinophilic myositis with mepolizumab. Indian J Rheumatol 2018 ; 13 : 289. [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.